Abstract:To investigate the effects of interleukin (IL)-17-mediated autophagy on the TNF receptor associated factor (TRAF6)/extracellular signal-regulated kinase (ERK)/p38 pathway and osteoclast differentiation. Mouse bone marrow-derived macrophages (BMM) were cultured with a medium containing 30 ng/mL macrophage colony stimulating factor and 50 ng/mL receptor activator of nuclear factor-kappa B ligard (RANKL), and IL-17 (0.01, 0.1, 1.0, 10 ng/mL) was added for intervention (IL-17 group). Tartrate-resistant acid phosphatase (TRAP) staining was used to observe TRAP positive multinucleated cells; phalloidin fluorescent staining was used to detect actin ring circumference; toluidine blue staining was used to analyze bone resorption lacuna formation. To further examine the mechanism of the effect of IL-17-mediated autophagy on the differentiation of osteoclasts, the control group used RANKL medium to culture mouse macrophage RAW264.7 cells, while the IL-17 group was treated with IL-17 (0.01, 0.1, 1.0, /mL). Western blot was used to detect the expression of autophagy-related proteins Beclin-1, microtubule-associated protein 1 light chain 3 (LC3) and osteoclast-related proteins c-fos and nuclear factor of activated T cell 1 (NFATc1) after treatment with different concentrations of IL-17. The expression of LC3, NFATc1, TRAF6/ERK/p38 signaling pathway related proteins were detected in IL-17 and autophagy inhibitor 3-MA group. The number of TRAP positive multinucleated cells, the circumference of the actin ring and the area of bone resorption lacuna in IL-17 group treated with IL-17 (0.01, 0.1, were significantly higher than those in the control group. In IL-17 treated RAW264.7 cells, the expression of c-fos, NFATc1, Beclin-1, LC3, TRAF6, p-ERK, and p-p38 was all significantly up-regulated (all 0.05). After treatment with the autophagy inhibitor 3-MA, the expression levels of LC3, NFATc1, TRAF6, p-ERK, and p-p38 all decreased significantly (all 0.05). IL-17 can promote the expression of autophagy proteins and enhance the differentiation ability of osteoclast precursor cells, and the TRAF6/ERK/p38 signaling pathway may be involved in this process.

ERK 1/2 and P38 MAPK Mediate the Effect of BAPTA-AM Inhibiting RANKL-induced Bone Marrow Macrophages Differentiation

BAPTA-AM, an Intracellular Calcium Chelator, Inhibits RANKL-induced Bone Marrow Macrophages Differentiation Through MEK/ERK, P38 MAPK and Akt, but Not JNK Pathways

Mineralizing Solution and Dexamethasone Enhance Receptor Activator for NF-κB Ligand Expression in Rat Bone Marrow Stromal Cells

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

TRAF6/ERK/p38 Pathway is Involved in Interleukin-17-mediated Autophagy to Promote Osteoclast Precursor Cell Differentiation.

Effect of P38mapk Inhibition on Receptor Activator of Nuclear Factor-Κb Ligand and Osteoprotegerin Expressions in Osteoblasts

Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation.

p44/42 and p38 MAPKs exert differences functions in osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cell cultures

Involvement of MAPK Pathway in the Osteoblastic Differentiation of Mouse Mesenchymal Stem Cells

Augmentation of TNF-induced osteoclast differentiation by inhibition of ERK and activation of p38: Similar intracellular signaling between RANKL- and TNF-induced osteoclast differentiation

D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways

Mek/Erk And P38 Mapk Regulate Chondrogenesis Of Rat Bone Marrow Mesenchymal Stem Cells Through Delicate Interaction With Tgf-Beta 1/Smads Pathway

Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.

Protaetia brevitarsis Extract Attenuates RANKL-Induced Osteoclastogenesis by Inhibiting the JNK/NF-κB/PLCγ2 Signaling Pathway

The Role of Cannabinoid Receptor 2 Selective Antagonist in Osteoclast Differentiation of RAW264.7 Cells

Periplaneta Americana extract inhibits osteoclastic differentiation in vitro

Role of P2×7 Receptor in the Differentiation of Bone Marrow Stromal Cells into Osteoblasts and Adipocytes

P38a Mapk Is Involved In Bmp-2-Induced Odontoblastic Differentiation Of Human Dental Pulp Cells

ERK Signaling Regulates RANKL Expression Induced by Metal Ions in MC3T3E1 Murine Calvarial Preosteoblastic Cells.

Effects of Bortezomib on Osteodastogenesis in Patients with Multiple Myeloma and Their Action Mechanism

Cannabinoid Receptor-2 Selective Antagonist Negatively Regulates Receptor Activator of Nuclear Factor Kappa B Ligand Mediated Osteoclastogenesis